Ozempic and Anti-Aging Benefits

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Recent studies highlight the potential anti-aging benefits of Ozempic, primarily known for treating type 2 diabetes and obesity, especially focusing on semaglutide, its active ingredient. Research presented at the European Society of Cardiology Conference in 2024 indicates that semaglutide may reduce biological aging by lowering inflammation and decreasing the risk of age-related diseases. The select trial, involving over 17,000 participants aged 45 or older with cardiovascular disease, demonstrated that those taking semaglutide showed lower overall mortality rates, including reduced fatalities from cardiovascular issues and COVID-19. Moreover, the drug appears beneficial for conditions associated with inflammation, such as cancer, Alzheimer’s, and Parkinson’s disease. Notably, the drug’s advantages extend beyond weight loss, suggesting its anti-aging effects may reach a broader demographic. However, Ozempic carries risks, including nausea and stomach pain, and has been linked to a rare eye condition that can result in significant vision loss. Ongoing research is essential to evaluate these benefits alongside the potential risks, emphasizing that Ozempic should be used under medical supervision for approved purposes.

We'd love to hear from you! Send us a text message.

In this episode of "Discover Daily" by Perplexity, we explore new research suggesting that Ozempic, a drug primarily used for treating Type 2 diabetes and obesity, may have potential anti-aging benefits. Studies presented at the European Society of Cardiology conference in 2024 revealed that semaglutide, the active ingredient in Ozempic, could slow down biological aging by reducing inflammation and lowering the risk of age-related diseases. However, Ozempic isn't without risks, including potential vision changes and eye problems in some patients.

We also delve into California's Digital Replica Bill (AB 1836), recently passed by the state Senate, which aims to regulate the use of AI-generated likenesses of deceased performers in media. The bill requires explicit consent from estates of deceased performers before creating digital replicas and establishes legal protections against unauthorized use. This legislation is part of a broader effort in California to regulate artificial intelligence and digital rights, following the passage of AB 2602, which requires informed consent and proper representation for alive performers when they are asked to waive rights to their digital personas.

Our final segment focuses on a fascinating study from researchers at MIT and the University of California, Irvine, revealing that conversational AI powered by large language models can significantly amplify the creation of false memories in humans. The study found that generative chatbots induced nearly triple the number of false memories compared to control groups, raising important questions about the ethical use of AI in sensitive contexts like legal proceedings and clinical settings. As we continue to explore the intersection of AI and human cognition, this research reminds us of the complex and sometimes unexpected ways technology can impact our minds.

From Perplexity's Discover Feed:

https://www.perplexity.ai/page/ozempic-may-delay-aging-ueDtRO0PRKiJf4icvqQ5Ig

https://www.perplexity.ai/page/california-digital-replicas-bi-Jp.QEJe4QXiOwdButE4Zyw

https://www.perplexity.ai/page/ai-amplifies-false-memories-Oi2YlbzuSyqDnm4m.RoxHw

Redeem a free year of Perplexity Pro through Xfinity Rewards

Perplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you’re interested in.

Take the world's knowledge with you anywhere. Available on iOS and Android

Join our growing Discord community for the latest updates and exclusive content.

Follow us on: